Association of CYP2D6 and CYP2C19 polymorphisms and disease-free survival of Thai post-menopausal breast cancer patients who received adjuvant tamoxifen

References

• FisherBCostantinoJPWickerhamDLTamoxifen for the prevention of breast cancer: current status of the National Surgical Adjuvant Breast and Bowel Project P-1 studyJ Natl Cancer Inst200597221652166216288118
   PubMed Web of Science ®Google Scholar
• ColleoniMGelberSGoldhirschATamoxifen after adjuvant chemotherapy for premenopausal women with lymph node-positive breast cancer: International Breast Cancer Study Group Trial 13-93J Clin Oncol20062491332134116505417
   PubMed Web of Science ®Google Scholar
• OsborneCKTamoxifen in the treatment of breast cancerN Engl J Med199833922160916189828250
   PubMed Web of Science ®Google Scholar
• DalyAKPharmacogenetics of the major polymorphic metabolizing enzymesFundam Clin Pharmacol2003171274112588628
   PubMed Web of Science ®Google Scholar
• Ingelman-SundbergMSimSCGomezARodriguez-AntonaCInfluence of cytochrome P450 polymorphisms on drug therapies: pharmacogenetic, pharmacoepigenetic and clinical aspectsPharmacol Ther2007116349652618001838
   PubMed Web of Science ®Google Scholar
• HoskinsJMCareyLAMcLeodHLCYP2D6 and tamoxifen: DNA matters in breast cancerNat Rev Cancer20099857658619629072
   PubMed Web of Science ®Google Scholar
• StearnsVJohnsonMDRaeJMActive tamoxifen metabolite plasma concentrations after coadministration of tamoxifen and the selective serotonin reuptake inhibitor paroxetineJ Natl Cancer Inst200395231758176414652237
   PubMed Web of Science ®Google Scholar
• JinYDestaZStearnsVCYP2D6 genotype, antidepressant use, and tamoxifen metabolism during adjuvant breast cancer treatmentJ Natl Cancer Inst2005971303915632378
   PubMed Web of Science ®Google Scholar
• LimYCLiLDestaZEndoxifen, a secondary metabolite of tamoxifen, and 4-OH-tamoxifen induce similar changes in global gene expression patterns in MCF-7 breast cancer cellsJ Pharmacol Exp Ther2006318250351216690721
   PubMed Web of Science ®Google Scholar
• KubotaTYamauraYOhkawaNHaraHChibaKFrequencies of CYP2D6 mutant alleles in a normal Japanese population and metabolic activity of dextromethorphan O-demethylation in different CYP2D6 genotypesBr J Clin Pharmacol2000501313410886115
   PubMed Web of Science ®Google Scholar
• SachseCBrockmollerJBauerSRootsICytochrome P450 2D6 variants in a Caucasian population: allele frequencies and phenotypic consequencesAm J Hum Genet19976022842959012401
   PubMed Web of Science ®Google Scholar
• GrieseEUAsante-PokuSOfori-AdjeiDMikusGEichelbaumMAnalysis of the CYP2D6 gene mutations and their consequences for enzyme function in a West African populationPharmacogenetics19999671572310634134
   PubMedGoogle Scholar
• XuYSunYYaoLAssociation between CYP2D6 *10 genotype and survival of breast cancer patients receiving tamoxifen treatmentAnn Oncol20081981423142918407954
   PubMed Web of Science ®Google Scholar
• SirachainanEJaruhathaiSTrachuNCYP2D6 polymorphisms influence the efficacy of adjuvant tamoxifen in Thai breast cancer patientsPharmgenomics Pers Med2012514915323226070
   PubMedGoogle Scholar
• SukasemCSirachainanEChamnanphonMImpact of CYP2D6 polymorphisms on tamoxifen responses of women with breast cancer: a microarray-based study in ThailandAsian Pac J Cancer Prev20121394549455323167378
   PubMedGoogle Scholar
• LimJSChenXASinghOImpact of CYP2D6, CYP3A5, CYP2C9 and CYP2C19 polymorphisms on tamoxifen pharmacokinetics in Asian breast cancer patientsBr J Clin Pharmacol201171573775021480951
   PubMed Web of Science ®Google Scholar
• van SchaikRHKokMSweepFCThe CYP2C19*2 genotype predicts tamoxifen treatment outcome in advanced breast cancer patientsPharmacogenomics20111281137114621830868
   PubMed Web of Science ®Google Scholar
• MillerSADykesDDPoleskyHFA simple salting out procedure for extracting DNA from human nucleated cellsNucleic Acids Res198816312153344216
   PubMed Web of Science ®Google Scholar
• SchrothWHamannUFaschingPACYP2D6 polymorphisms as predictors of outcome in breast cancer patients treated with tamoxifen: expanded polymorphism coverage improves risk stratificationClin Cancer Res201016174468447720515869
   PubMed Web of Science ®Google Scholar
• MurdterTESchrothWBacchus-GerybadzeLActivity levels of tamoxifen metabolites at the estrogen receptor and the impact of genetic polymorphisms of phase I and II enzymes on their concentration levels in plasmaClin Pharmacol Ther201189570871721451508
   PubMed Web of Science ®Google Scholar
• GoetzMPKnoxSKSumanVJThe impact of cytochrome P450 2D6 metabolism in women receiving adjuvant tamoxifenBreast Cancer Res Treat2007101111312117115111
   PubMed Web of Science ®Google Scholar
• LimHSJu LeeHSeok LeeKSook LeeEJangIJRoJClinical implications of CYP2D6 genotypes predictive of tamoxifen pharmacokinetics in metastatic breast cancerJ Clin Oncol200725253837384517761971
   PubMed Web of Science ®Google Scholar
• KiyotaniKMushirodaTSasaMImpact of CYP2D6*10 on recurrence-free survival in breast cancer patients receiving adjuvant tamoxifen therapyCancer Sci200899599599918294285
   PubMed Web of Science ®Google Scholar
• OkishiroMTaguchiTJin KimSShimazuKTamakiYNoguchiSGenetic polymorphisms of CYP2D6*10 and CYP2C19*2,*3 are not associated with prognosis, endometrial thickness, or bone mineral density in Japanese breast cancer patients treated with adjuvant tamoxifenCancer2009115595296119156902
   PubMed Web of Science ®Google Scholar
• ToyamaTYamashitaHSugiuraHKondoNIwaseHFujiiYNo association between CYP2D6*10 genotype and survival of node-negative Japanese breast cancer patients receiving adjuvant tamoxifen treatmentJpn J Clin Oncol2009391065165619596663
   PubMed Web of Science ®Google Scholar
• WegmanPElingaramiSCarstensenJStalONordenskjoldBWingrenSGenetic variants of CYP3A5, CYP2D6, SULT1A1, UGT2B15 and tamoxifen response in postmenopausal patients with breast cancerBreast Cancer Res200791R717244352
   PubMed Web of Science ®Google Scholar
• ZangerUMRaimundoSEichelbaumMCytochrome P450 2D6: overview and update on pharmacology, genetics, biochemistryNaunyn Schmiedebergs Arch Pharmacol20043691233714618296
   PubMed Web of Science ®Google Scholar